Cite
HARVARD Citation
Curtin, F. et al. (2018). A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody. Diabetes, obesity & metabolism. 20 (9), pp. 2075-2084. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Curtin, F. et al. (2018). A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody. Diabetes, obesity & metabolism. 20 (9), pp. 2075-2084. [Online].